The future of biomedical innovation depends in part on a new trend for all players in biomedical innovation to work together for the common goal, say 2 MIT researchers
It’s a long, expensive, risky road to turn a scientific breakthrough into a treatment that can help patients. Fewer organizations are trying to tackle the challenges alone, says a new paper from MIT researchers published August 28 in the journal Science Translational Medicine.
An essential new way to move discoveries forward has emerged in the form of multi-stakeholder collaborations involving three or more different types of organizations, such as drug companies, government regulators and patient groups, write Magdalini Papadaki, a research associate, and Gigi Hirsch, a physician-entrepreneur and executive director of the MIT Center for Biomedical Innovation.
The authors are calling for a new “science of collaboration” to learn what works and doesn’t work; to improve how leaders can design, manage and evaluate collaborations; and to help educate and train future leaders with the necessary organizational and managerial skills.
“Getting new, better, affordable drugs to the right patients faster involves a series of historically independent decisions made by different players or stakeholders,” says Hirsch. The system is uncoordinated, takes too long, and costs too much. In some cases, the drug—such as new antibiotics for life-threatening resistant infections—may never become available.
“One of the interesting paradoxes of biomedical innovation is increasingly going to be that even though we have the scientific knowledge required to provide potentially better treatments for patients—or even to prevent disease in those who are at high risk—we may be unable to help patients benefit from them anytime soon,” she says.
To help change this scenario, in the last decade, thousands of researchers, pharmaceutical and biotechnology companies, government regulators, payers, clinicians and patients have come together in more than 100 multi-stakeholder collaborations to solve some specific shared problem standing in the way of finding a cure or a better diagnostic approach.
“Multi-stakeholder collaborations provide the opportunity to create an environment that allows for new kinds of interactions among the players,” Hirsch says. The largest multi-stakeholder effort, the European Union’s Innovative Medicines Initiative (IMI) began in 2008 and has established more than 40 consortia with financial and in-kind investments totaling €2 billion. Some projects focus on specific health issues, such as Alzheimer’s disease, chronic pain, diabetes and obesity. Others tackle bigger issues, such as drug and vaccine safety and the use of stem cells for drug discovery. The success has led to a proposal to extend the effort for 10 years and €3.5 billion. Last year, the U.S. President’s Council of Advisors on Science and Technology (PCAST) recommended the U.S. form something similar.
“The prevalence of multi-stakeholder initiatives reflects a continued optimism about the value of this collaboration approach for addressing biomedical innovation bottlenecks,” the authors write in the paper. “Although the need for collaboration is no longer in question, it is worth noting the importance of this development. A willingness to share proprietary data among industry competitors represents a dramatic shift in the culture of the historically highly competitive pharmaceutical industry.”
The article reviews the history of collaborations beginning with HIV/AIDS. By the early 2000s, multi-stakeholder collaborations proliferated to address the need for important tools, such as biomarkers, that require preclinical data sharing. Since then, they have reached to encompass later stages in product development, including manufacturing, reimbursement and post-market monitoring.
Some people involved in multi-stakeholder consortia are concerned about redundancy, inefficiency and lack of productivity of some collaborative efforts, all contributing to a sense of “consortium fatigue,” the researchers write.
In a newer trend, funders and participants are seeking a smaller number of strategically coordinated initiatives that will reliably address critical gaps, Hirsch and Papadaki write. They cite the example of TransCelerate BioPharma, a group of 10 major pharmaceutical companies that came together to share and direct resources toward selected priorities in order to improve the efficiency of drug development, such as clinical trial site qualification standards.
The authors propose a rigorous evidence-based approach (the science of collaboration) to figure out what works and doesn’t work in collaborations. They recommend early steps in this new field and structuring the research to help learn from the past but also to evolve effectively as new innovation challenges emerge.
The Latest on: Science of collaboration
- From Idea To Impact on December 17, 2018 at 2:15 am
Here are four strategies to boost industry-academia collaboration. AsianScientist (Dec. 17, 2018) – Many ground-breaking innovations have their humble beginnings in academia. For instance, Alan Turing ... […]
- Forbion Portfolio Company Staten Biotechnology Enters into a Collaboration with Novo Nordisk to Develop Novel Treatment for D... on December 16, 2018 at 11:32 pm
Forbion today announces that its portfolio company Staten Biotechnology B.V. and Novo Nordisk A/S have entered into a collaboration and exclusive option agreement to develop novel therapeutics for the ... […]
- Forbion Portfolio Company Staten Biotechnology Enters into a Collaboration with Novo Nordisk to Develop Novel Treatment for Dyslipidaemia on December 16, 2018 at 10:30 pm
Claim your 2-week free trial here. NAARDEN, The Netherlands & MUNICH--(BUSINESS WIRE)-- Forbion today announces that its portfolio company Staten Biotechnology B.V. and Novo Nordisk A/S have entered i... […]
- Scholastic Support: IAEA Works with Academic and National Nuclear Institutions to Foster Closer Collaboration around Nuclear Science and Technology on December 13, 2018 at 5:20 am
From industrial radiographers to nuclear medicine practitioners, millions of professionals around the world regularly deploy radioactive sources and isotopes as a function of their work. Ensuring that ... […]
- BT and Indian Institute Of Science To Establish A Collaborative Research Centre In Bangalore on December 12, 2018 at 9:52 pm
BT is partnering with the Indian Institute of Science (IISc), one of India’s leading research institutions, to launch a new collaborative research centre in Bangalore, it was announced today. The new ... […]
- Researcher’s Atomic-Level Work Makes Material Difference in MIT Study on December 12, 2018 at 1:02 pm
One clear example of the latter is Yifan Nie, a University of Texas at Dallas graduate student in materials science and engineering who will earn his PhD next week. Nie’s research has focused on devel... […]
- Argentina eyes science-tech collaboration with Qatar on December 12, 2018 at 11:38 am
Argentina is exploring the possibilities of collaboration in science and technology with Qatar, the South American nation's Foreign Minister Jorge Faurie has said. "Argentina is also looking for Qatar... […]
- Collaborative vision takes photonics into the future on December 8, 2018 at 4:32 am
“I wanted to turn that science fiction into reality ... As vice-rector of the Vrije Universiteit, he has also been tasked with boosting collaboration with industry. He considers promoting the economic ... […]
- 'Science of Addiction' explores new research, collaboration between disciplines on December 6, 2018 at 5:00 pm
Allison Cho, Claire Colby and Zipei Lin 3 min ago The science of addiction is complex and nuanced, but researchers and experts are making strides in understanding addiction better and researching new ... […]
- Faculty-student collaborative research gains national visibility on December 5, 2018 at 5:26 pm
Research at Willamette opens doors to students' future. Experiments Nance conducted last summer through the university’s Science Collaborative Research Program, similar to his work for Griffith’s gran... […]
via Google News and Bing News